FDA, NIH initiative aims to speed development of drugs for ALS, other brain diseases
Bio Pharma Dive
SEPTEMBER 16, 2022
The public-private partnership plans to bring together scientific experts, private entities and patient groups to better understand certain neurodegenerative disorders and find new treatments.
Let's personalize your content